BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9020173)

  • 21. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
    Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression.
    Tommasi S; Pfeifer GP
    Mol Cell Biol; 1995 Dec; 15(12):6901-13. PubMed ID: 8524257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive protection of E2F recognition sequences in the human thymidine kinase promoter during cell cycle progression.
    Tommasi S; Pfeifer GP
    J Biol Chem; 1997 Nov; 272(48):30483-90. PubMed ID: 9374541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell cycle regulation of E2F site occupation in vivo.
    Zwicker J; Liu N; Engeland K; Lucibello FC; Müller R
    Science; 1996 Mar; 271(5255):1595-7. PubMed ID: 8599118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
    Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
    Hsiao KM; McMahon SL; Farnham PJ
    Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inverted repeat motif stabilizes binding of E2F and enhances transcription of the dihydrofolate reductase gene.
    Wade M; Blake MC; Jambou RC; Helin K; Harlow E; Azizkhan JC
    J Biol Chem; 1995 Apr; 270(17):9783-91. PubMed ID: 7730357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ; Jones NC
    Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD; Farlie PG; Watson RJ
    Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo.
    Blake MC; Azizkhan JC
    Mol Cell Biol; 1989 Nov; 9(11):4994-5002. PubMed ID: 2601705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspase-dependent apoptosis by ectopic expression of E2F-4.
    Chang YC; Nakajima H; Illenye S; Lee YS; Honjo N; Makiyama T; Fujiwara I; Mizuta N; Sawai K; Saida K; Mitsui Y; Heintz NH; Magae J
    Oncogene; 2000 Sep; 19(41):4713-20. PubMed ID: 11032021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bidirectionally transcribed dihydrofolate reductase and rep-3a promoters are growth regulated by distinct mechanisms.
    Schilling LJ; Farnham PJ
    Cell Growth Differ; 1995 May; 6(5):541-8. PubMed ID: 7647037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
    Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
    EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest.
    Knudsen KE; Fribourg AF; Strobeck MW; Blanchard JM; Knudsen ES
    J Biol Chem; 1999 Sep; 274(39):27632-41. PubMed ID: 10488103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter.
    Park KK; Rue SW; Lee IS; Kim HC; Lee IK; Ahn JD; Kim HS; Yu TS; Kwak JY; Heintz NH; Magae J; Chang YC
    Biochem Biophys Res Commun; 2003 Jun; 306(1):239-43. PubMed ID: 12788094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.